JAK3 associates with the human interleukin 4 receptor and is tyrosine phosphorylated following receptor triggering

Oncogene. 1995 May 4;10(9):1757-61.

Abstract

In human B cells, interleukin 4 (IL4) acts in regulating proliferation, antigen expression, isotype switching and differentiation. These different effects are mediated through the IL4R complex including the IL2R gamma chain (gamma c) and a specific p130/140 binding unit referred below as human Interleukin 4 Receptor (IL4-R). Here, we studied the signal transduction events following IL4R activation and leading to CD23 expression on resting B cells. We demonstrate that IL4R triggering induced the tyrosine phosphorylation of JAK3 and of a p170 protein. Coimmunoprecipitation of JAK3 with the IL4R suggests a physical association which exists prior to IL4R complex stimulation. Orthovanadate treatment, while having no effect on IL4-induced p130 phosphorylation, leads to the hyperphosphorylation of the p170 and inhibits IL4-induced CD23 expression. These suggest that two mandatory steps exist in early IL4 signaling: one controlled by JAK3 activation and the other by the p170 phosphoprotein.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • B-Lymphocytes / metabolism*
  • Child
  • Humans
  • Interleukin-4 / pharmacology
  • Janus Kinase 2
  • Janus Kinase 3
  • Lymphocyte Activation
  • Palatine Tonsil
  • Phosphorylation
  • Phosphotyrosine
  • Protein-Tyrosine Kinases / metabolism*
  • Proto-Oncogene Proteins*
  • Receptors, Interleukin / metabolism*
  • Receptors, Interleukin-4
  • Signal Transduction
  • Tyrosine / analogs & derivatives
  • Tyrosine / metabolism

Substances

  • Proto-Oncogene Proteins
  • Receptors, Interleukin
  • Receptors, Interleukin-4
  • Interleukin-4
  • Phosphotyrosine
  • Tyrosine
  • Protein-Tyrosine Kinases
  • JAK2 protein, human
  • JAK3 protein, human
  • Janus Kinase 2
  • Janus Kinase 3